Skip to main content

Second Chakra (Sacral)

NDC 63083-7302 · Professional Complementary Health Formulas

Generic nameSecond Chakra (Sacral)
Dosage formLIQUID
RouteORAL
Active ingredient(s)HELLEBORUS NIGER ROOT, STRYCHNOS IGNATII SEED, POTASSIUM CHLORATE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, ARTEMISIA CINA PRE-FLOWERING TOP, BOS TAURUS BILE, LACHESIS MUTA VENOM, SEPIA OFFICINALIS JUICE, SILICON DIOXIDE
Strength10; 12; 8; 12; 8; 8; 12; 30; 8 [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL
Pharmacologic classCalculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
Marketing categoryUNAPPROVED HOMEOPATHIC

Packages

63083-7302-1 — 29.5 mL in 1 BOTTLE, DROPPER (63083-7302-1)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

63083-7005 — RET Kidney, 63083-7006 — RET Bladder, 63083-7007 — RET Gallbladder, 63083-7009 — RET Heart, 63083-7011 — RET Thyroid/Adrenal, 63083-7012 — RET Pituitary/Sex, 63083-7122 — Ignatia amara, 63083-7124 — Lachesis mutus, 63083-7134 — Sepia, 63083-7301 — First Chakra (Root), 63083-7303 — Third Chakra (Solar Plexus), 63083-7304 — Fourth Chakra (Heart), 63083-7305 — Fifth Chakra (Throat), 63083-7306 — Sixth Chakra (Third Eye), 63083-7534 — Weight Management Formula, 63083-8008 — Magnesia Phosphorica, 63083-8012 — Silicea, 63083-8013 — Cell Salt Combination, 63083-8142 — Rose Quartz, 63083-9203 — Aletris Combination, +1613 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources